These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 13599021)

  • 1. Concentrative uptake of azaserine by neoplastic plasma cells and lymphocytes.
    PINE EK
    J Natl Cancer Inst; 1958 Nov; 21(5):973-84. PubMed ID: 13599021
    [No Abstract]   [Full Text] [Related]  

  • 2. Resistance in L1210 ascites without change in concentrative uptake of o-diazoacetyl-L-serine or 6-diazo-5-oxo-L-norleucine.
    JACQUEZ JA; HUTCHISON DJ
    Cancer Res; 1959 May; 19(4):397-401. PubMed ID: 13652124
    [No Abstract]   [Full Text] [Related]  

  • 3. Concentrative uptake of 6-diazo-5-oxo-L-norleucine by sarcoma 180, liver and muscle in vivo.
    JACQUEZ JA
    Proc Soc Exp Biol Med; 1958 Dec; 99(3):611-3. PubMed ID: 13614439
    [No Abstract]   [Full Text] [Related]  

  • 4. Observations on the action of azaserine in mammalian tissues.
    HENDERSON JF; LEPAGE GA; MCIVER FA
    Cancer Res; 1957 Jul; 17(6):609-12. PubMed ID: 13446847
    [No Abstract]   [Full Text] [Related]  

  • 5. Active transport of O-diazoacetyl-L-serine and 6-diazo-5-oxo-L-norleucine in Ehrlich ascites carcinoma.
    JACQUEZ JA
    Cancer Res; 1957 Oct; 17(9):890-6. PubMed ID: 13472680
    [No Abstract]   [Full Text] [Related]  

  • 6. Enzymatic degradation of azaserine.
    JACQUEZ JA; SHERMAN JH
    Cancer Res; 1962 Jan; 22():56-61. PubMed ID: 14450824
    [No Abstract]   [Full Text] [Related]  

  • 7. In vivo sensitivity of normal and neoplastic mouse tissues to azaserine.
    MOORE EC; LEPAGE GA
    Cancer Res; 1957 Sep; 17(8):804-8. PubMed ID: 13460988
    [No Abstract]   [Full Text] [Related]  

  • 8. [In vitro effects of azaserine on normal and neoplastic tissue; polarographic behavior of azaserine].
    SANTAMARIA L
    Farmaco Sci; 1955; 10(11):897-909. PubMed ID: 13294172
    [No Abstract]   [Full Text] [Related]  

  • 9. [On the effect of azaserine and azaserine with 6-mercaptopurine on the Yoshida sarcoma].
    YAMAGUCHI H; KURAHORI T; KUSUMOTO G; TERASHITA N; TABUCHI Y; ICHIHARA G; TOKITA Y; IKEDA E; FUKUI S
    Gan; 1956 Dec; 47(3-4):385-6. PubMed ID: 13415049
    [No Abstract]   [Full Text] [Related]  

  • 10. Uptake of radioactive phosphorus in experimental tumors. III. The biochemical fate of P32 in normal and neoplastic ocular tissue.
    THOMAS CI; HARRINGTON H; BOVINGTON MS
    Cancer Res; 1958 Oct; 18(9):1008-11. PubMed ID: 13596941
    [No Abstract]   [Full Text] [Related]  

  • 11. Azaserine resistance in a plasma-cell neoplasm without change in active transport of the inhibitor.
    ANDERSON EP; JACQUEZ JA
    Cancer Res; 1962 Jan; 22():27-37. PubMed ID: 13861221
    [No Abstract]   [Full Text] [Related]  

  • 12. Cytochemical effects of azaserine on Ehrlich ascites tumor cells; action on deoxyribose nucleic acid (DNA) and total protein.
    LINDNER A
    AMA Arch Pathol; 1957 Jun; 63(6):532-9. PubMed ID: 13423969
    [No Abstract]   [Full Text] [Related]  

  • 13. Culture of neoplastic mast cells and their synthesis of 5-hydroxytryptamine and histamine in vitro.
    SCHINDLER R; DAY M; FISCHER GA
    Cancer Res; 1959 Jan; 19(1):47-51. PubMed ID: 13618883
    [No Abstract]   [Full Text] [Related]  

  • 14. Chromatographic studies of purine metabolism. IV. Reversal of azaserine-induced inhibition by phenylalanine and tryptophan.
    TOMISEK AJ; REID MR; SKIPPER HE
    Cancer Res; 1959 Jun; 19(5):489-93. PubMed ID: 13663035
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of combinations of azaserine and of 6-diazo-5-oxo-L-norleucine with purine analogs and other antimetabolites on the growth of two mouse mammary carcinomas.
    TARNOWSKI GS; STOCK CC
    Cancer Res; 1957 Nov; 17(10):1033-9. PubMed ID: 13489704
    [No Abstract]   [Full Text] [Related]  

  • 16. The metabolism of 6-thioguanine in normal and neoplastic tissues.
    MOORE EC; LePAGE GA
    Cancer Res; 1958 Oct; 18(9):1075-83. PubMed ID: 13596951
    [No Abstract]   [Full Text] [Related]  

  • 17. Inhibition of glucolysis and fructolysis of Krebs 2 ascites carcinoma cells by chemical agents.
    YUSHOK WD
    Cancer Res; 1958 Sep; 18(8 Part 2):379-89. PubMed ID: 13573386
    [No Abstract]   [Full Text] [Related]  

  • 18. Metabolism of neoplastic tissue. XIV. Methylglyoxal formation during glucose catabolism in tumors.
    LEWIS KF; MAJANE EH; WEINHOUSE S
    Cancer Res; 1959 Jan; 19(1):97-100. PubMed ID: 13618892
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical trials of O-diazoacetyl-L-serine (azaserine) in neoplastic disease.
    ELLISON RR; KARNOFSKY DA; STERNBERG SS; MURPHY ML; BURCHENAL JH
    Cancer; 1954 Jul; 7(4):801-14. PubMed ID: 13172694
    [No Abstract]   [Full Text] [Related]  

  • 20. Azaserine: pathological and pharmacological studies.
    STERNBERG SS; PHILIPS FS
    Cancer; 1957; 10(5):889-901. PubMed ID: 13472634
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.